Adverse effects of iodixanol: A retrospective safety study utilizing FAERS database signal analysis
database[Title] 2025-12-10
Summary:
This retrospective study utilized the Food and Drug Administration adverse event (AE) reporting system database (Q1 2004-Q4 2024) to comprehensively evaluate the safety profile of the contrast agent iodixanol. Disproportionality analysis (reporting odds ratio, proportional reporting ratio, information component, empirical Bayes geometric mean) was employed to detect AE signals. Analysis of 2212 iodixanol AE reports revealed an increasing reporting trend, peaking in 2014 (10.85%). Males reported...